-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse Gettex System der Börse MünchenSymbol LX31-
LEXICON PHARMACEUTICALS INCBörse Börse StuttgartSymbol LX31
-
LEXICON PHARMACEUTICALS INCBörse Gettex System der Börse MünchenSymbol LX31
-
LEXICON PHARMACEUTICALS INCBörse Tradegate System der Deutsche Börse AG (60%)Symbol LX31
-
ISIN US5288723027 WKN: A14SSKSymbol LXRX
-
Symbol LX31
-
Symbol LX31
-
Symbol LX31
-
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.075.377.152 oder 575.000.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
184 oder 135 Mitarbeiter
Dir gefallen die Informationen zu Lexicon Pharmaceuticals, Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Lexicon Pharmaceuticals, Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Lexicon Pharmaceuticals, Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Lexicon Pharmaceuticals, Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
27 News & Informationen zur Lexicon Pharmaceuticals, Inc. Aktie
Lexicon Welcomes New ESC Heart Failure Treatment Guidelines Establishing SGLT Inhibitors As Standard Of Care
New guidelines from the European Society of Cardiology recommend addition of SGLT inhibitors to standard of care for patients with acute and chronic heart
60 Biggest Movers From Friday
Gainers Vinco Ventures, Inc. (NASDAQ:BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per s…
Lexicon's Sotagliflozin Demonstrates Additional Compelling Benefits In Reducing Cardiovascular Endpoints: Results From Soloist And Scored Trials
Rapid benefit of sotagliflozin supported by data from the SOLOIST and SCORED trials presented at ESC Congress 2021 – The Digital Experience, including:
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Tops Revenue Estimates
Lexicon (LXRX) delivered earnings and revenue surprises of 18.75% and 680.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical Officer
THE WOODLANDS, Texas, July 30, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that Craig Granowitz, M.D., Ph.D….
Lexicon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical Update
Conference Call and Webcast at 8:00 am Eastern Time…
Earnings Scheduled For July 30, 2021
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its second quarter.
• …
Lexicon Pharmaceuticals Announces Symposium At The American Diabetes Association 81st Scientific Sessions
THE WOODLANDS, Texas, June 25, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today there will be a symposium highlighting
The Week Ahead In Biotech: FDA To Issue Decisions On Merck And Aurinia Drug Applications
Biotech stocks advanced in the week ended Jan. 15, defying the softness experienced by the broader market. Pre-announcements continued to pour in, with most …
The Week Ahead In Biotech: FDA To Issue Decisions On Merck And Aurinia Drug Applications
Biotech stocks advanced in the week ended Jan. 15, defying the softness experienced by the broader market. Pre-announcements continued to pour in,…
Why Lexicon Pharmaceuticals Stock Is Down Today
A downgrade from an analyst might have something to do with it.
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …
FDA Expands Approved Use Of PFE's Xalkori, LXRX Soars On Sotagliflozin Update, BCYC Hits New High
Today's Daily Dose brings you news about Lexicon's regulatory update on Sotagliflozin in heart failure; FDA approval of Pfizer's XALKORI in a new indication; Bicycle's pipeline progress update and Organogenesis' progress in knee osteoarthritis trial.
Why Lexicon Pharmaceuticals Stock Doubled and Then Some on Thursday
The FDA delivered a powerful shot of good news to the company.
US Indexes Close Lower Thursday
US Indexes Close Lower Thursday, Stocks: JPM,C,WFC,PYPL,GOOG,GOOGL,GME,LXRX,POTX, release date:Jan 14, 2021
Why Lexicon Pharma's Stock Is Surging Higher Today
Lexicon Pharmaceuticals (NASDAQ: LXRX) shares are trading sharply higher after the company announced it received FDA regulatory feedback that the results of …
LXRX Stock Alert: Why Lexicon Pharmaceuticals Is Up 100%+ Today
Lexicon Pharmaceuticals (LXRX) stock is on the rise Thursday after announcing an update from the FDA for its drug sotagliflozin.
Mid-Afternoon Market Update: Dow Rises 75 Points; Acacia Communications Shares Spike Higher
Toward the end of trading Thursday, the Dow traded up 0.24% to 31,135 while the NASDAQ rose 0.27% to 13,164.28. The S&P also rose, gaining 0.08% to …
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Lexicon Pharmaceuticals (NASDAQ:LXRX) stock moved upwards by 78.57% to $7.0 during Thursday's regular session. Trading volume for this …
Mid-Day Market Update: Volt Information Sciences Drops After Q4 Results; Lexicon Pharmaceuticals Shares Jump
Midway through trading Thursday, the Dow traded up 0.42% to 31,189.88 while the NASDAQ rose 0.35% to 13,175.48. The S&P also rose, gaining 0.15% to …
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
Noteworthy Points: Taiwan Semiconductor (NYSE:TSM) was the largest firm on a …
Stocks of Note for Jan-14 Morning
Mid-Morning Market Update: Markets Open Higher; Delta Air Lines Posts Wider-Than-Expected Loss
Following the market opening Thursday, the Dow traded up 0.43% to 31,195.15 while the NASDAQ rose 0.53% to 13,199.16. The S&P also rose, gaining 0.32% …
Stock Alert: Lexicon Pharmaceuticals Surges 35%
Shares of Lexicon Pharmaceuticals, Inc. (LXRX) are currently gaining over 35% after the company said it received a regulatory feedback that clears a key hurdle for partnership discussions around sotagliflozin in heart failure.
Is Lexicon Pharma a Stock to Buy After 90% Runup and FDA Nod? – 24
Lexicon Pharma shares jumped on Thursday morning after the company announced that it received regulatory feedback from the FDA regarding its heart failure treatment.
The Best Penny Stocks To Buy Right Now? 1 Analyst Sees 137% Upside
5 Penny Stocks To Buy According To Analysts & Price Targets Up To 243%